Related Experiment Video
Updated: Jan 21, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M Jackson1, John Choi1, Michael Lim2
1Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Glioblastoma (GBM) is the deadliest form of brain cancer, with a median survival of less than 2 years despite surgical resection, radiation, and chemotherapy. GBM's rapid progression, resistance to therapy, and inexorable recurrence have been attributed to several factors, including its rapid growth rate, its molecular heterogeneity, its propensity to infiltrate vital brain structures, the regenerative capacity of treatment-resistant cancer stem cells, and challenges in achieving high concentrations of chemotherapeutic agents in the central nervous system. Escape from immunosurveillance is increasingly recognized as a landmark event in cancer biology. Translation of this framework to clinical oncology has positioned immunotherapy as a pillar of cancer treatment. Amid the bourgeoning successes of cancer immunotherapy, GBM has emerged as a model of resistance to immunotherapy. Here we review the mechanisms of immunotherapy resistance in GBM and discuss how insights into GBM-immune system interactions might inform the next generation of immunotherapeutics for GBM and other resistant pathologies.
Insights
Glioblastoma (GBM) is a deadly brain cancer resistant to current treatments. Understanding GBM
Area of Science:
- Neuro-oncology
- Cancer immunology
- Translational medicine
Background:
- Glioblastoma (GBM) is the most aggressive primary brain tumor with poor prognosis.
- Therapeutic resistance and tumor recurrence are hallmarks of GBM.
- Immunotherapy has revolutionized cancer treatment but shows limited efficacy in GBM.
Purpose of the Study:
- To review the mechanisms underlying Glioblastoma's resistance to immunotherapy.
- To explore GBM-immune system interactions.
- To inform the development of novel immunotherapeutics for Glioblastoma.
Main Methods:
- Literature review
- Synthesis of current research on Glioblastoma immunology
- Analysis of immune evasion strategies in Glioblastoma
Main Results:
- Glioblastoma exhibits multiple mechanisms of immune resistance.
- Tumor heterogeneity, the immunosuppressive tumor microenvironment, and intrinsic cancer cell properties contribute to immunotherapy failure.
- Specific immune checkpoints and cellular interactions impede anti-tumor immunity in GBM.
Conclusions:
- Glioblastoma's resistance to immunotherapy is multifactorial.
- Targeting GBM-immune interactions is crucial for developing effective immunotherapies.
- Future strategies may involve combination therapies to overcome Glioblastoma's immune evasion.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...

